Cancer Loves Statin Drugs
According to the National Institute of Health approximately 1.5 million men and women were diagnosed with cancer in 2009. One in every two individuals will be diagnosed with cancer in their lifetime. As of 2006 there were approximately 11.4 million men and women in the US who have or are fighting cancer. More and more reports are being made available implicating statin drugs and the spread of cancer.
In reading the following keep in mind that statin drugs are a 12.5 billion dollar industry. 16 million Americans are currently taking Lipitor alone. The drug companies are targeting an additional 36 million more potential "customers".
Small malignant tumors need nutrients to grow, invade nearby tissue and develop new colonies of cancer cells. To do this cancer cells release chemical signals to nearby blood vessels to stimulate the growth of new vessels to the cancer cells. This is called angiogenesis.
Tumor cells can also seed metastatic sites even in early stages of cancer detection. Most of these cells don't survive long. However, some viable cells can remain dormant and resistant to conventional therapies. These dormant cancer cells can become active and begin to proliferate many years later. Their ability to do this depends on the availability of an adequate blood supply.
In a study by Dr Michael Simons at the Beth Israel Deaconess Medical Center in Boston, statins, especially Zocor, were shown to promote angiogenesis, which is good for patients with cardiovascular damage, but not good for the 1.3 million individuals diagnosed with cancer every year.
In addition, all cholesterol lowering drugs diminish the effectiveness of T-cells and natural killer cells that attack malignant cells. During their clinical trials statin drugs caused cancer in every lab animal tested. In one study female statin drug users had an increase of breast cancer by 1500%.
A very well known study (PROSPER) reported a 25% increase in cancer among the elderly being treated with pravastatin (pravachol). Other studies on women taking pravastatin showed 12 cases of breast cancer compared to only one in the untreated group. This confirmed multiple animal studies that reported the link between the statin drugs and cancer.
If you're interested in learning what you can do to lower your cholesterol without using statin drugs go to Correcting Cholesterol Without Drugs
KOLESTER is an effective cholesterol lowering herbal used by my clients instead of statin drugs along with a cholesterol lowering program.
Sarcoma Muscle Cancer
A sarcoma muscle cancer is a highly malignant and rare type of cancer that arises in the connective tissues in the body.There are approximately 9,800 new cases of soft tissue and bone sarcoma each year in the United States. It is rare among adults and accounts for less than 2% of all adult cancers. This type of cancer is more common in children and sarcoma is one of the top five most commonly diagnosed cancers among children.
Sarcoma muscle cancer is not the only type of sarcoma seen clinically. Soft tissue sarcomas are malignant tumors that can develop from fat, muscle, nerve, fibrous tissues surrounding joints, blood vessel, or deep skin tissues. Sarcomas can develop in any part of the body. Around 55% to 60% of them develop in the arms or legs. Fifteen to twenty percent begin in the trunk, eight to ten percent in head and neck area and internal organs and around fifteen per cent originate at the back of the abdominal cavity. Sarcoma is the term used for cancers of these tissues.
The human body has 2 types of muscle: smooth and skeletal. Smooth skeletal muscle is found internal organs such as stomach, intestines and blood vessels and causes them to contract. These muscles are involuntary and hence we have no control over their functioning. Skeletal muscle is the muscle is attached to bones and aids in our movement. This type of muscle in within our control and are also called voluntary muscles. Leiomyomas are benign tumors of smooth muscle. They can arise almost anywhere in the body where smooth muscles are present. The most common of these is the fibroid tumor that develops in many women. Leiomyosarcomas are sarcoma muscle cancer of involuntary muscle tissue. They can grow almost anywhere in the body but are most often found in the back of the abdominal cavity and the internal organs and blood vessels. Occasionally, they may affect the deep soft tissues of the legs or arms. They tend to occur in adults, particularly the elderly. Rhabdomyomas are benign tumors of skeletal muscle. They are rare tumors. Rhabdomyosarcomas are malignant tumors of skeletal muscle. These tumors commonly grow in the arms or legs, but they can also begin in the head and neck area and in reproductive and urinary organs such as the vagina or bladder. Children are affected much more often than adults.
Surgery is the primary treatment for sarcoma muscle cancer. The main goal of surgery is to remove the tumor and at least two to three centimeters of the surrounding tissue. In the past amputation of an arm or leg was a standard treatment for soft tissue sarcomas of the extremities. Owing to advancements in surgical practice, nowadays, amputations are performed in only about five percent of cases nationwide. Most small sarcomas can be treated with surgery alone but the majority of sarcomas are greater than five centimeters in size. These sarcomas are usually managed using a combination of surgery and radiation therapy. Radiation therapy may be used before, during, and after surgery.